Gene · 2255
Papers3,603
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,603
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metformin for treatment of cytopenias in children and young adults with Fanconi anemia. | Blood Adv | 2022 | 35500223 | PubTator, text mining | PubMed |
| A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer. | Sci Adv | 2022 | 35486727 | PubTator, text mining | PubMed |
| Systematic evaluation of colorectal cancer organoid system by single-cell RNA-Seq analysis. | Genome Biol | 2022 | 35484598 | PubTator, text mining | PubMed |
| Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade. | Br J Cancer | 2022 | 35484215 | PubTator, text mining | PubMed |
| TGS1 mediates 2,2,7-trimethyl guanosine capping of the human telomerase RNA to direct telomerase dependent telomere maintenance. | Nat Commun | 2022 | 35484160 | PubTator, text mining | PubMed |
| Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer. | Redox Biol | 2022 | 35483272 | PubTator, text mining | PubMed |
| New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis. | Circ Res | 2022 | 35482831 | PubTator, text mining | PubMed |
| miR-29b-3p Inhibitor Alleviates Hypomethylation-Related Aberrations Through a Feedback Loop Between miR-29b-3p and DNA Methylation in Cardiomyocytes. | Front Cell Dev Biol | 2022 | 35478963 | PubTator, text mining | PubMed |
| Cellular Reprogramming and Its Potential Application in Alzheimer's Disease. | Front Neurosci | 2022 | 35464309 | PubTator, text mining | PubMed |
| Lapatinib Suppresses HER2-Overexpressed Cholangiocarcinoma and Overcomes ABCB1- Mediated Gemcitabine Chemoresistance. | Front Oncol | 2022 | 35463361 | PubTator, text mining | PubMed |
| A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumors. | Mol Ther | 2022 | 35462042 | PubTator, text mining | PubMed |
| Mouse models in palate development and orofacial cleft research: Understanding the crucial role and regulation of epithelial integrity in facial and palate morphogenesis. | Curr Top Dev Biol | 2022 | 35461563 | PubTator, text mining | PubMed |
| Next-Generation Sequencing Screening of 43 Families with Non-Syndromic Early-Onset High Myopia: A Clinical and Genetic Study. | Int J Mol Sci | 2022 | 35457050 | PubTator, text mining | PubMed |
| The Tumor Microenvironment Drives Intrahepatic Cholangiocarcinoma Progression. | Int J Mol Sci | 2022 | 35457006 | PubTator, text mining | PubMed |
| The Evaluation of FGFR1, FGFR2 and FOXO1 in Orofacial Cleft Tissue. | Children (Basel) | 2022 | 35455561 | PubTator, text mining | PubMed |
| Induction of Stem-Cell-Derived Cardiomyogenesis by Fibroblast Growth Factor 10 (FGF10) and Its Interplay with Cardiotrophin-1 (CT-1). | Biology (Basel) | 2022 | 35453733 | PubTator, text mining | PubMed |
| Cell Type-Specific Anti-Adhesion Properties of Peritoneal Cell Treatment with Plasma-Activated Media (PAM). | Biomedicines | 2022 | 35453677 | PubTator, text mining | PubMed |
| Extremely Low-Frequency Electromagnetic Fields Increase Cytokines in Human Hair Follicles through Wnt/β-Catenin Signaling. | Biomedicines | 2022 | 35453674 | PubTator, text mining | PubMed |
| Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity. | Nat Commun | 2022 | 35449156 | PubTator, text mining | PubMed |
| Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research. | J Neuropathol Exp Neurol | 2022 | 35446393 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2255/papers?page=48